- Home
- QSR vs STE Comparison
QSR vs STE Comparison
Compare QSR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSR
- STE
- Stock Information
- Founded
- QSR 1954
- STE 1985
- Country
- QSR Canada
- STE United States
- Employees
- QSR N/A
- STE N/A
- Industry
- QSR
- STE Industrial Specialties
- Sector
- QSR
- STE Health Care
- Exchange
- QSR Nasdaq
- STE Nasdaq
- Market Cap
- QSR N/A
- STE 23.9B
- IPO Year
- QSR 2006
- STE 1992
- Fundamental
- Price
- QSR $68.27
- STE $238.05
- Analyst Decision
- QSR Buy
- STE Buy
- Analyst Count
- QSR 19
- STE 9
- Target Price
- QSR $77.74
- STE $261.00
- AVG Volume (30 Days)
- QSR 4.1M
- STE 546.3K
- Earning Date
- QSR 08-07-2025
- STE 08-05-2025
- Dividend Yield
- QSR 3.64%
- STE 0.96%
- EPS Growth
- QSR N/A
- STE 63.01
- EPS
- QSR 2.94
- STE 6.21
- Revenue
- QSR $8,776,000,000.00
- STE $5,459,515,000.00
- Revenue This Year
- QSR $9.51
- STE $7.61
- Revenue Next Year
- QSR $3.22
- STE $6.04
- P/E Ratio
- QSR $23.21
- STE $38.35
- Revenue Growth
- QSR 22.38
- STE 6.24
- 52 Week Low
- QSR $58.71
- STE $200.98
- 52 Week High
- QSR $75.07
- STE $252.79
- Technical
- Relative Strength Index (RSI)
- QSR 54.42
- STE 47.49
- Support Level
- QSR $64.44
- STE $236.73
- Resistance Level
- QSR $68.49
- STE $243.08
- Average True Range (ATR)
- QSR 1.09
- STE 3.66
- MACD
- QSR 0.06
- STE -0.32
- Stochastic Oscillator
- QSR 94.57
- STE 39.00
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.